Sarepta Therapeutics Inc. (SRPT) NASDAQ
$118.59 (2.63) (-2.17%)
Market Cap: $10.67B
As of 10/02/23 04:00 PM EDT. Market closed.

Sarepta Therapeutics Inc. (SRPT)
NASDAQ
$118.59
(2.63) (-2.17%)
Market Cap: $10.67B
As of 10/02/23 04:00 PM EDT. Market closed.
sarepta therapeutics is a biopharmaceutical company focused on the discovery and development of unique rna-targeted therapeutics for the treatment of rare, infectious and other diseases. the company is primarily focused on rapidly advancing the development of its potentially disease-modifying dmd drug candidates, including its lead dmd product candidate, eteplirsen, designed to skip exon 51. ... read more
sarepta therapeutics is a biopharmaceutical company focused on the discovery and development of unique rna-targeted therapeutics for the treatment of rare, infectious and other diseases. the company is primarily focused on rapidly advancing the development of its potentially disease-modifying dmd drug candidates, including its lead dmd product candidate, eteplirsen, designed to skip exon 51. sarepta is also developing therapeutics for the treatment of infectious diseases, such as drug-resistant bacteria and other rare human diseases. for more information, please visit us at www.sarepta.com. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Chambers Michael Andrew | Director | Aug 14, 2023 | Buy | $109.47 | 9,979 | 1,092,429 | 246,996 | Aug 15, 2023, 08:00 AM |
Chambers Michael Andrew | Director | Aug 11, 2023 | Buy | $108.05 | 23,686 | 2,559,272 | 237,017 | Aug 14, 2023, 08:00 AM |
Chambers Michael Andrew | Director | Aug 10, 2023 | Buy | $106.15 | 34,867 | 3,701,067 | 213,331 | Aug 11, 2023, 07:40 AM |
Wigzell Hans Lennart Rudolf | Director | Aug 04, 2023 | Option Exercise | $29.03 | 15,000 | 435,450 | 35,994 | Aug 08, 2023, 08:00 PM |
Wigzell Hans Lennart Rudolf | Director | Aug 04, 2023 | Sale | $106.72 | 15,000 | 1,600,800 | 20,994 | Aug 08, 2023, 08:00 PM |
Brown Ryan Edward | EVP, General Counsel | Jun 01, 2023 | Option Exercise | $123.60 | 89 | 11,000 | 28,096 | Jun 05, 2023, 08:00 PM |
Arif Bilal | Chief Tech Ops Officer | Mar 30, 2023 | Option Exercise | $136.66 | 307 | 41,955 | 26,367 | Apr 04, 2023, 08:00 PM |
Rodino-Klapac Louise | Head of R&D, CSO | Mar 08, 2023 | Option Exercise | $153.19 | 912 | 139,709 | 70,170 | Mar 10, 2023, 08:00 PM |
Estepan Ian Michael | Chief Financial Officer | Mar 08, 2023 | Option Exercise | $153.19 | 744 | 113,973 | 34,679 | Mar 10, 2023, 08:00 PM |
Brown Ryan Edward | SVP, General Counsel | Mar 08, 2023 | Option Exercise | $153.19 | 635 | 97,276 | 28,185 | Mar 10, 2023, 08:00 PM |
Arif Bilal | Chief Tech Ops Officer | Mar 08, 2023 | Option Exercise | $153.19 | 314 | 48,102 | 26,674 | Mar 10, 2023, 08:00 PM |
Arif Bilal | Chief Tech Ops Officer | Mar 06, 2023 | Option Exercise | $157.21 | 340 | 53,451 | 22,642 | Mar 08, 2023, 08:00 PM |
Estepan Ian Michael | Chief Financial Officer | Mar 06, 2023 | Option Exercise | $157.21 | 1,370 | 215,378 | 30,923 | Mar 08, 2023, 08:00 PM |
Rodino-Klapac Louise | Head of R&D, CSO | Mar 06, 2023 | Option Exercise | $157.21 | 1,134 | 178,276 | 66,582 | Mar 08, 2023, 08:00 PM |
Brown Ryan Edward | SVP, General Counsel | Mar 06, 2023 | Option Exercise | $157.21 | 1,325 | 208,303 | 24,491 | Mar 08, 2023, 08:00 PM |
Arif Bilal | Chief Tech Ops Officer | Mar 01, 2023 | Option Exercise | $147.57 | 252 | 37,188 | 22,837 | Mar 03, 2023, 08:01 PM |
Brown Ryan Edward | SVP, General Counsel | Mar 01, 2023 | Option Exercise | $147.57 | 196 | 28,924 | 25,645 | Mar 03, 2023, 08:01 PM |
Estepan Ian Michael | Chief Financial Officer | Mar 01, 2023 | Option Exercise | $147.57 | 378 | 55,781 | 32,293 | Mar 03, 2023, 08:00 PM |
Rodino-Klapac Louise | Head of R&D, CSO | Mar 01, 2023 | Option Exercise | $147.57 | 522 | 77,032 | 67,716 | Mar 03, 2023, 08:00 PM |
BEHRENS M KATHLEEN | Director | Dec 19, 2022 | Option Exercise | $34.92 | 20,000 | 698,400 | 158,470 | Dec 21, 2022, 09:05 AM |
Rodino-Klapac Louise | Head of R&D, CSO | Nov 17, 2022 | Option Exercise | $108.52 | 4,211 | 456,978 | 67,998 | Nov 21, 2022, 08:02 PM |
Mayo Stephen | Director | Nov 17, 2022 | Sale | $109.92 | 858 | 94,311 | 6,387 | Nov 21, 2022, 08:00 PM |
Chambers Michael Andrew | Director | Sep 14, 2022 | Buy | $104.43 | 57,100 | 5,963,124 | 108,178 | Sep 15, 2022, 08:00 AM |
Chambers Michael Andrew | Director | Aug 19, 2022 | Buy | $108.28 | 46,170 | 4,999,230 | 51,078 | Aug 22, 2022, 08:30 AM |
Brown Ryan Edward | SVP, General Counsel | Jun 01, 2022 | Option Exercise | $72.67 | 54 | 3,924 | 25,841 | Jun 03, 2022, 08:00 PM |
Estepan Ian Michael | Chief Financial Officer | Mar 07, 2022 | Option Exercise | $79.36 | 398 | 31,585 | 24,671 | Mar 08, 2022, 08:02 PM |
Estepan Ian Michael | Chief Financial Officer | Mar 04, 2022 | Option Exercise | $79.20 | 1,308 | 103,594 | 25,069 | Mar 08, 2022, 08:02 PM |
Brown Ryan Edward | SVP, General Counsel | Mar 07, 2022 | Option Exercise | $79.36 | 153 | 12,142 | 17,895 | Mar 08, 2022, 08:02 PM |
Brown Ryan Edward | SVP, General Counsel | Mar 04, 2022 | Option Exercise | $79.20 | 1,136 | 89,971 | 18,048 | Mar 08, 2022, 08:02 PM |
Ciambrone William | EVP | Mar 04, 2022 | Option Exercise | $79.20 | 1,160 | 91,872 | 14,099 | Mar 08, 2022, 08:01 PM |
Rodino-Klapac Louise | Head of R&D, CSO | Mar 04, 2022 | Option Exercise | $79.20 | 1,216 | 96,307 | 64,111 | Mar 08, 2022, 08:00 PM |
Rodino-Klapac Louise | Head of R&D, CSO | Mar 01, 2022 | Option Exercise | $75.05 | 572 | 42,929 | 65,327 | Mar 01, 2022, 08:03 PM |
Estepan Ian Michael | Chief Financial Officer | Mar 01, 2022 | Option Exercise | $75.05 | 376 | 28,219 | 26,377 | Mar 01, 2022, 08:02 PM |
Brown Ryan Edward | SVP, General Counsel | Mar 01, 2022 | Option Exercise | $75.05 | 184 | 13,809 | 19,184 | Mar 01, 2022, 08:01 PM |
BEHRENS M KATHLEEN | Director | Dec 15, 2021 | Option Exercise | $10.08 | 5,000 | 50,400 | 135,517 | Dec 16, 2021, 08:00 PM |
Rodino-Klapac Louise | Head of R&D, CSO | Nov 24, 2021 | Buy | $79.33 | 3,780 | 299,867 | 65,678 | Nov 29, 2021, 08:00 AM |
INGRAM DOUGLAS S | President & CEO | Nov 17, 2021 | Buy | $79.94 | 25,026 | 2,000,579 | 365,082 | Nov 17, 2021, 06:24 PM |
Estepan Ian Michael | Chief Financial Officer | Sep 08, 2021 | Option Exercise | $78.29 | 1,623 | 127,065 | 26,753 | Sep 09, 2021, 08:00 PM |
INGRAM DOUGLAS S | President & CEO | Jun 26, 2021 | Option Exercise | $80.40 | 17,812 | 1,432,085 | 340,056 | Jun 28, 2021, 08:00 PM |
BEHRENS M KATHLEEN | Director | Mar 10, 2021 | Option Exercise | $42.30 | 5,000 | 211,500 | 135,517 | Mar 10, 2021, 08:04 PM |
BEHRENS M KATHLEEN | Director | Mar 10, 2021 | Sale | $85.76 | 5,000 | 428,800 | 130,517 | Mar 10, 2021, 08:04 PM |
Wigzell Hans Lennart Rudolf | Director | Mar 08, 2021 | Option Exercise | $34.92 | 10,000 | 349,200 | 26,518 | Mar 10, 2021, 08:03 PM |
Wigzell Hans Lennart Rudolf | Director | Mar 08, 2021 | Sale | $83.51 | 10,000 | 835,100 | 16,518 | Mar 10, 2021, 08:03 PM |
O'Neill Gilmore Neil | EVP, R&D & CMO | Feb 28, 2021 | Option Exercise | $86.97 | 524 | 45,572 | 13,546 | Mar 10, 2021, 08:02 PM |
Brown Ryan Edward | SVP, General Counsel | Mar 04, 2021 | Option Exercise | $80.76 | 190 | 15,344 | 19,432 | Mar 10, 2021, 08:01 PM |
Brown Ryan Edward | SVP, General Counsel | Feb 28, 2021 | Option Exercise | $86.97 | 216 | 18,786 | 4,622 | Mar 10, 2021, 08:01 PM |
Rodino-Klapac Louise | Chief Scientific Officer | Feb 28, 2021 | Option Exercise | $86.97 | 565 | 49,138 | 6,604 | Mar 10, 2021, 08:01 PM |
Estepan Ian Michael | Chief Financial Officer | Mar 05, 2021 | Option Exercise | $84.65 | 347 | 29,374 | 28,376 | Mar 10, 2021, 08:00 PM |
Estepan Ian Michael | Chief Financial Officer | Feb 28, 2021 | Option Exercise | $86.97 | 319 | 27,743 | 13,723 | Mar 10, 2021, 08:00 PM |
INGRAM DOUGLAS S | President & CEO | Dec 31, 2020 | Option Exercise | $170.49 | 37,144 | 6,332,681 | 357,868 | Jan 04, 2021, 08:00 PM |
Bratica Joseph | Principal Financial Officer | Dec 11, 2020 | Option Exercise | $71.45 | 1,115 | 79,667 | 9,255 | Dec 14, 2020, 08:00 PM |
Bratica Joseph | Principal Financial Officer | Dec 11, 2020 | Sale | $165.00 | 1,115 | 183,975 | 8,140 | Dec 14, 2020, 08:00 PM |
Bratica Joseph | Principal Financial Officer | Dec 08, 2020 | Option Exercise | $29.60 | 1,125 | 33,300 | 9,265 | Dec 10, 2020, 08:23 PM |
Bratica Joseph | Principal Financial Officer | Dec 08, 2020 | Sale | $160.00 | 1,125 | 180,000 | 8,140 | Dec 10, 2020, 08:23 PM |
Wigzell Hans Lennart Rudolf | Director | Aug 10, 2020 | Option Exercise | $34.92 | 10,000 | 349,200 | 23,792 | Aug 11, 2020, 08:00 PM |
Wigzell Hans Lennart Rudolf | Director | Aug 10, 2020 | Sale | $159.00 | 10,000 | 1,590,044 | 14,569 | Aug 11, 2020, 08:00 PM |
Barry Richard | Director | Aug 07, 2020 | Sale | $158.50 | 30,000 | 4,754,972 | 3,132,280 | Aug 07, 2020, 08:00 PM |
Bratica Joseph | Principal Financial Officer | Aug 03, 2020 | Option Exercise | $29.60 | 1,125 | 33,300 | 8,957 | Aug 05, 2020, 08:00 PM |
Bratica Joseph | Principal Financial Officer | Aug 03, 2020 | Sale | $155.00 | 1,125 | 174,375 | 7,832 | Aug 05, 2020, 08:00 PM |
Mahatme Sandesh | EVP, CFO & CBO | Jul 08, 2020 | Option Exercise | $19.69 | 3,806 | 74,941 | 20,260 | Jul 09, 2020, 08:00 PM |
Howton David T | EVP, General Counsel | Jun 22, 2020 | Option Exercise | $25.76 | 105,122 | 2,708,440 | 136,993 | Jun 22, 2020, 09:17 PM |
Howton David T | EVP, General Counsel | Jun 22, 2020 | Sale | $170.88 | 105,122 | 17,962,831 | 130,984 | Jun 22, 2020, 09:17 PM |
Wigzell Hans Lennart Rudolf | Director | May 20, 2020 | Option Exercise | $10.08 | 5,000 | 50,400 | 18,792 | May 22, 2020, 08:00 PM |
Wigzell Hans Lennart Rudolf | Director | May 20, 2020 | Sale | $150.64 | 5,000 | 753,210 | 16,692 | May 22, 2020, 08:00 PM |
Barry Richard | Director | May 15, 2020 | Sale | $141.26 | 30,000 | 4,237,946 | 3,163,813 | May 15, 2020, 09:02 PM |
Wigzell Hans Lennart Rudolf | Director | Mar 04, 2020 | Option Exercise | $8.46 | 5,000 | 42,300 | 18,792 | Mar 06, 2020, 08:01 PM |
Wigzell Hans Lennart Rudolf | Director | Mar 04, 2020 | Sale | $116.89 | 5,000 | 584,450 | 13,792 | Mar 06, 2020, 08:01 PM |
INGRAM DOUGLAS S | President & CEO | Dec 31, 2019 | Option Exercise | $129.04 | 37,185 | 4,798,352 | 395,012 | Jan 03, 2020, 08:00 PM |
Cumbo Alexander | EVP, Chief Commercial Officer | Dec 13, 2019 | Option Exercise | $23.70 | 32,706 | 775,232 | 43,867 | Dec 17, 2019, 08:02 PM |
Cumbo Alexander | EVP, Chief Commercial Officer | Dec 13, 2019 | Sale | $125.50 | 42,000 | 5,271,000 | 11,161 | Dec 17, 2019, 08:02 PM |
Howton David T | EVP, General Counsel | Dec 13, 2019 | Option Exercise | $21.48 | 78,000 | 1,675,439 | 103,171 | Dec 17, 2019, 08:01 PM |
Howton David T | EVP, General Counsel | Dec 13, 2019 | Sale | $125.50 | 78,000 | 9,789,000 | 25,171 | Dec 17, 2019, 08:01 PM |
Mahatme Sandesh | EVP, CFO & CBO | Dec 13, 2019 | Option Exercise | $28.88 | 125,000 | 3,610,443 | 155,179 | Dec 17, 2019, 08:00 PM |
Mahatme Sandesh | EVP, CFO & CBO | Dec 13, 2019 | Sale | $125.50 | 125,000 | 15,687,500 | 30,179 | Dec 17, 2019, 08:00 PM |
Howton David T | EVP, General Counsel | Nov 22, 2019 | Option Exercise | $107.02 | 2,804 | 300,084 | 25,171 | Nov 26, 2019, 08:01 PM |
Howton David T | EVP, General Counsel | Nov 22, 2019 | Option Exercise | $16.13 | 34,272 | 552,667 | 36,993 | Nov 26, 2019, 08:01 PM |
Howton David T | EVP, General Counsel | Nov 22, 2019 | Sale | $105.00 | 25,000 | 2,625,000 | 18,703 | Nov 26, 2019, 08:01 PM |
Barry Richard | Director | Sep 13, 2019 | Buy | $87.49 | 3,309 | 289,504 | 3,187,065 | Sep 16, 2019, 08:00 AM |
Barry Richard | Director | Sep 12, 2019 | Buy | $87.49 | 1,691 | 147,950 | 3,183,756 | Sep 16, 2019, 08:00 AM |
BONNEY MICHAEL W | Director | Sep 09, 2019 | Buy | $86.74 | 2,000 | 173,480 | 7,051 | Sep 09, 2019, 02:18 PM |
BEHRENS M KATHLEEN | Director | Sep 05, 2019 | Option Exercise | $7.80 | 5,000 | 39,000 | 123,167 | Sep 06, 2019, 02:13 PM |
BEHRENS M KATHLEEN | Director | Sep 06, 2019 | Buy | $87.98 | 2,500 | 219,950 | 125,667 | Sep 06, 2019, 02:13 PM |
Mahatme Sandesh | EVP, CFO & CBO | Aug 21, 2019 | Option Exercise | $101.50 | 57,465 | 5,832,698 | 72,714 | Aug 22, 2019, 07:20 PM |
Mahatme Sandesh | EVP, CFO & CBO | Aug 21, 2019 | Option Exercise | $23.85 | 100,000 | 2,385,000 | 130,179 | Aug 22, 2019, 07:20 PM |
Barry Richard | Director | Aug 20, 2019 | Buy | $99.32 | 5,000 | 496,592 | 3,182,065 | Aug 20, 2019, 05:43 PM |
Mahatme Sandesh | EVP, CFO & CBO | Aug 15, 2019 | Option Exercise | $24.73 | 9,754 | 241,232 | 30,179 | Aug 15, 2019, 04:33 PM |
Barry Richard | Director | Aug 14, 2019 | Buy | $122.50 | 3,700 | 453,250 | 3,177,065 | Aug 14, 2019, 04:38 PM |
Barry Richard | Director | Aug 12, 2019 | Buy | $122.50 | 1,300 | 159,250 | 3,173,365 | Aug 13, 2019, 04:31 PM |
INGRAM DOUGLAS S | President & CEO | Aug 12, 2019 | Buy | $123.07 | 16,252 | 2,000,160 | 432,197 | Aug 12, 2019, 05:48 PM |
O'Neill Gilmore Neil | EVP, R&D & CMO | May 24, 2019 | Option Exercise | $119.31 | 4,630 | 552,405 | 7,370 | May 24, 2019, 08:07 PM |
Wigzell Hans Lennart Rudolf | Director | May 23, 2019 | Option Exercise | $7.80 | 10,000 | 78,000 | 21,717 | May 24, 2019, 08:03 PM |
Wigzell Hans Lennart Rudolf | Director | May 23, 2019 | Sale | $120.00 | 10,000 | 1,200,000 | 11,717 | May 24, 2019, 08:03 PM |
Mahatme Sandesh | EVP, CFO & CBO | Mar 28, 2019 | Option Exercise | $118.68 | 2,953 | 350,462 | 20,425 | Mar 29, 2019, 08:01 PM |
Howton David T | EVP, General Counsel | Mar 28, 2019 | Option Exercise | $118.68 | 2,362 | 280,322 | 18,703 | Mar 29, 2019, 08:00 PM |
Cumbo Alexander | EVP, Chief Commercial Officer | Mar 28, 2019 | Option Exercise | $118.68 | 2,165 | 256,942 | 11,161 | Mar 29, 2019, 07:59 PM |
Mahatme Sandesh | EVP, CFO & CBO | Mar 19, 2019 | Option Exercise | $126.47 | 2,625 | 331,984 | 16,729 | Mar 20, 2019, 08:00 PM |
Mahatme Sandesh | EVP, CFO & CBO | Mar 19, 2019 | Option Exercise | $21.46 | 15,486 | 332,308 | 19,354 | Mar 20, 2019, 08:00 PM |
Mahatme Sandesh | EVP, CFO & CBO | Feb 07, 2019 | Option Exercise | $23.85 | 65,000 | 1,550,250 | 73,649 | Feb 08, 2019, 08:02 PM |
Mahatme Sandesh | EVP, CFO & CBO | Feb 07, 2019 | Sale | $145.00 | 65,000 | 9,425,000 | 8,649 | Feb 08, 2019, 08:02 PM |
Cumbo Alexander | SVP, Chief Commercial Officer | Feb 01, 2019 | Option Exercise | $22.54 | 7,500 | 169,035 | 30,266 | Feb 01, 2019, 08:27 PM |
Cumbo Alexander | SVP, Chief Commercial Officer | Feb 01, 2019 | Sale | $140.00 | 15,000 | 2,100,000 | 15,266 | Feb 01, 2019, 08:27 PM |
Howton David T | SVP, General Counsel | Feb 01, 2019 | Option Exercise | $21.65 | 21,500 | 465,391 | 49,571 | Feb 01, 2019, 08:25 PM |
Howton David T | SVP, General Counsel | Feb 01, 2019 | Sale | $140.00 | 30,000 | 4,200,000 | 19,571 | Feb 01, 2019, 08:25 PM |
Mahatme Sandesh | EVP, CFO & CBO | Jan 31, 2019 | Option Exercise | $23.85 | 21,198 | 505,572 | 29,847 | Feb 01, 2019, 08:24 PM |
Mahatme Sandesh | EVP, CFO & CBO | Jan 30, 2019 | Option Exercise | $18.27 | 43,802 | 800,077 | 52,451 | Feb 01, 2019, 08:24 PM |
Mahatme Sandesh | EVP, CFO & CBO | Jan 31, 2019 | Sale | $130.72 | 21,198 | 2,771,003 | 8,649 | Feb 01, 2019, 08:24 PM |
Mahatme Sandesh | EVP, CFO & CBO | Jan 30, 2019 | Sale | $130.00 | 43,802 | 5,694,260 | 8,649 | Feb 01, 2019, 08:24 PM |
Wigzell Hans Lennart Rudolf | Director | Nov 01, 2018 | Option Exercise | $8.94 | 6,667 | 59,603 | 16,751 | Nov 02, 2018, 06:01 PM |
Wigzell Hans Lennart Rudolf | Director | Nov 01, 2018 | Sale | $140.50 | 6,667 | 936,714 | 10,084 | Nov 02, 2018, 06:01 PM |
BEHRENS M KATHLEEN | Director | Oct 31, 2018 | Option Exercise | $3.96 | 10,000 | 39,600 | 126,534 | Nov 02, 2018, 06:00 PM |
BEHRENS M KATHLEEN | Director | Oct 31, 2018 | Sale | $131.71 | 10,000 | 1,317,100 | 116,534 | Nov 02, 2018, 06:00 PM |
INGRAM DOUGLAS S | President & CEO | Oct 30, 2018 | Buy | $120.39 | 16,695 | 2,009,872 | 415,945 | Oct 30, 2018, 07:05 PM |
Mahatme Sandesh | EVP, CFO & CBO | Oct 24, 2018 | Option Exercise | $14.88 | 89,400 | 1,330,389 | 128,185 | Oct 26, 2018, 06:43 PM |
Mahatme Sandesh | EVP, CFO & CBO | Oct 24, 2018 | Sale | $127.74 | 107,524 | 13,735,116 | 20,661 | Oct 26, 2018, 06:43 PM |
INGRAM DOUGLAS S | President & CEO | Aug 15, 2018 | Buy | $125.26 | 16,000 | 2,004,208 | 399,250 | Aug 16, 2018, 07:30 AM |
Cumbo Alexander | SVP, Chief Commercial Officer | Aug 08, 2018 | Option Exercise | $121.02 | 6,000 | 726,120 | 22,766 | Aug 08, 2018, 06:16 PM |
Howton David T | SVP, General Counsel | Aug 08, 2018 | Option Exercise | $121.02 | 6,800 | 822,936 | 28,071 | Aug 08, 2018, 06:14 PM |
Mahatme Sandesh | EVP, CFO & CBO | Aug 08, 2018 | Option Exercise | $121.02 | 8,501 | 1,028,791 | 38,785 | Aug 08, 2018, 06:14 PM |
Howton David T | SVP, General Counsel | Jul 16, 2018 | Option Exercise | $13.85 | 50,000 | 692,691 | 72,719 | Jul 17, 2018, 06:01 PM |
Howton David T | SVP, General Counsel | Jul 16, 2018 | Sale | $136.46 | 50,000 | 6,823,000 | 34,871 | Jul 17, 2018, 06:01 PM |
Cumbo Alexander | SVP, Chief Commercial Officer | Jul 09, 2018 | Option Exercise | $13.78 | 33,782 | 465,415 | 40,690 | Jul 11, 2018, 06:05 PM |
Cumbo Alexander | SVP, Chief Commercial Officer | Jul 09, 2018 | Sale | $137.32 | 33,782 | 4,638,944 | 28,766 | Jul 11, 2018, 06:05 PM |
Barry Richard | Director | Jun 27, 2018 | Sale | $130.34 | 75,000 | 9,775,500 | 3,170,432 | Jun 29, 2018, 06:01 PM |
INGRAM DOUGLAS S | President & CEO | Jun 26, 2018 | Option Exercise | $135.53 | 36,946 | 5,007,291 | 383,250 | Jun 27, 2018, 05:24 PM |
Ruff Shamim | SVP, Chief Regulatory Affairs | May 22, 2018 | Option Exercise | $89.22 | 1,305 | 116,432 | 31,936 | May 24, 2018, 06:06 PM |
Mahatme Sandesh | EVP, CFO & CBO | May 22, 2018 | Option Exercise | $89.22 | 2,024 | 180,581 | 47,286 | May 24, 2018, 06:05 PM |
Howton David T | SVP, General Counsel | May 22, 2018 | Option Exercise | $89.22 | 1,566 | 139,719 | 34,871 | May 24, 2018, 06:05 PM |
Cumbo Alexander | SVP, Chief Commercial Officer | May 22, 2018 | Option Exercise | $89.22 | 1,435 | 128,031 | 28,766 | May 24, 2018, 06:04 PM |
Ruff Shamim | SVP, Chief Regulatory Affairs | Mar 15, 2018 | Option Exercise | $81.22 | 736 | 59,778 | 28,809 | Mar 16, 2018, 06:13 PM |
Ruff Shamim | SVP, Chief Regulatory Affairs | Mar 15, 2018 | Option Exercise | $23.93 | 2,500 | 59,813 | 29,465 | Mar 16, 2018, 06:13 PM |
Howton David T | SVP, General Counsel | Mar 15, 2018 | Option Exercise | $81.22 | 680 | 55,230 | 31,118 | Mar 16, 2018, 06:12 PM |
Howton David T | SVP, General Counsel | Mar 15, 2018 | Option Exercise | $22.15 | 2,500 | 55,382 | 31,727 | Mar 16, 2018, 06:12 PM |
Cumbo Alexander | SVP, Chief Commercial Officer | Mar 15, 2018 | Option Exercise | $81.22 | 633 | 51,412 | 25,325 | Mar 16, 2018, 06:10 PM |
Cumbo Alexander | SVP, Chief Commercial Officer | Mar 15, 2018 | Option Exercise | $20.64 | 2,500 | 51,600 | 25,767 | Mar 16, 2018, 06:10 PM |
Mahatme Sandesh | EVP, CFO & CBO | Mar 15, 2018 | Option Exercise | $81.22 | 734 | 59,615 | 42,661 | Mar 16, 2018, 06:08 PM |
Mahatme Sandesh | EVP, CFO & CBO | Mar 15, 2018 | Option Exercise | $23.85 | 2,500 | 59,625 | 43,395 | Mar 16, 2018, 06:08 PM |
Wigzell Hans Lennart Rudolf | Director | Nov 30, 2017 | Option Exercise | $7.38 | 6,667 | 49,202 | 13,333 | Dec 04, 2017, 08:00 PM |
Wigzell Hans Lennart Rudolf | Director | Nov 30, 2017 | Sale | $55.89 | 6,667 | 372,619 | 6,666 | Dec 04, 2017, 08:00 PM |
INGRAM DOUGLAS S | President & CEO | Nov 08, 2017 | Buy | $52.44 | 38,138 | 1,999,957 | 420,196 | Nov 13, 2017, 05:00 PM |
Ruff Shamim | SVP, Regulatory Affairs & Qual | Nov 06, 2017 | Option Exercise | $14.76 | 10,000 | 147,600 | 37,045 | Nov 08, 2017, 08:13 PM |
Ruff Shamim | SVP, Regulatory Affairs & Qual | Nov 06, 2017 | Sale | $55.00 | 10,000 | 550,000 | 27,045 | Nov 08, 2017, 08:13 PM |
Ruff Shamim | SVP, Regulatory Affairs & Qual | Oct 03, 2017 | Option Exercise | $14.76 | 11,500 | 169,740 | 38,545 | Oct 05, 2017, 07:24 PM |
Ruff Shamim | SVP, Regulatory Affairs & Qual | Oct 03, 2017 | Sale | $50.00 | 11,500 | 575,000 | 27,045 | Oct 05, 2017, 07:24 PM |
Ruff Shamim | SVP, Regulatory Affairs & Qual | Aug 03, 2017 | Option Exercise | $37.88 | 2,882 | 109,170 | 27,045 | Aug 07, 2017, 04:44 PM |
Mahatme Sandesh | EVP, CFO & CBO | Aug 03, 2017 | Option Exercise | $37.88 | 6,264 | 237,280 | 40,895 | Aug 07, 2017, 04:42 PM |
Howton David T | SVP, General Counsel | Aug 03, 2017 | Option Exercise | $37.88 | 4,642 | 175,839 | 29,298 | Aug 07, 2017, 04:40 PM |
Kaye Edward M. MD | Director | Aug 03, 2017 | Option Exercise | $37.88 | 16,703 | 632,710 | 71,229 | Aug 07, 2017, 04:39 PM |
Cumbo Alexander | SVP, Chief Commercial Officer | Aug 03, 2017 | Option Exercise | $37.88 | 3,169 | 120,042 | 23,458 | Aug 07, 2017, 04:38 PM |
INGRAM DOUGLAS S | President & CEO | Jul 27, 2017 | Buy | $42.50 | 47,058 | 1,999,965 | 382,058 | Jul 28, 2017, 08:51 AM |
Mahatme Sandesh | EVP, CFO & CBO | Jul 21, 2017 | Option Exercise | $23.85 | 1,500 | 35,775 | 33,861 | Jul 21, 2017, 09:49 PM |
Mahatme Sandesh | EVP, CFO & CBO | Jul 20, 2017 | Option Exercise | $15.38 | 50,000 | 769,107 | 65,359 | Jul 21, 2017, 09:49 PM |
Mahatme Sandesh | EVP, CFO & CBO | Jul 20, 2017 | Sale | $41.00 | 50,000 | 2,050,000 | 32,361 | Jul 21, 2017, 09:49 PM |
Kaye Edward M. MD | Director | Jul 20, 2017 | Option Exercise | $40.93 | 4,349 | 178,005 | 62,471 | Jul 21, 2017, 09:48 PM |
Kaye Edward M. MD | Director | Jul 20, 2017 | Sale | $41.00 | 10,000 | 410,000 | 52,471 | Jul 21, 2017, 09:48 PM |
Ruff Shamim | SVP, Regulatory Affairs & Qual | Jul 21, 2017 | Option Exercise | $14.12 | 5,888 | 83,133 | 25,450 | Jul 21, 2017, 09:47 PM |
Ruff Shamim | SVP, Regulatory Affairs & Qual | Jul 20, 2017 | Option Exercise | $13.71 | 6,250 | 85,688 | 27,312 | Jul 21, 2017, 09:47 PM |
Ruff Shamim | SVP, Regulatory Affairs & Qual | Jul 21, 2017 | Sale | $44.00 | 5,888 | 259,072 | 21,062 | Jul 21, 2017, 09:47 PM |
Ruff Shamim | SVP, Regulatory Affairs & Qual | Jul 20, 2017 | Sale | $42.00 | 6,250 | 262,500 | 21,062 | Jul 21, 2017, 09:47 PM |
Howton David T | SVP, General Counsel | Jul 20, 2017 | Option Exercise | $13.71 | 25,000 | 342,750 | 41,357 | Jul 21, 2017, 09:46 PM |
Howton David T | SVP, General Counsel | Jul 21, 2017 | Option Exercise | $20.56 | 1,000 | 20,565 | 23,301 | Jul 21, 2017, 09:46 PM |
Howton David T | SVP, General Counsel | Jul 20, 2017 | Sale | $41.00 | 25,000 | 1,025,000 | 22,301 | Jul 21, 2017, 09:46 PM |
Cumbo Alexander | SVP, Chief Commercial Officer | Jul 20, 2017 | Option Exercise | $13.71 | 2,500 | 34,275 | 22,793 | Jul 21, 2017, 09:45 PM |
Cumbo Alexander | SVP, Chief Commercial Officer | Jul 20, 2017 | Sale | $41.00 | 5,918 | 242,638 | 20,293 | Jul 21, 2017, 09:45 PM |
Kaye Edward M. MD | President & CEO | Apr 20, 2017 | Option Exercise | $32.54 | 4,349 | 141,516 | 66,820 | Apr 24, 2017, 05:11 PM |
Howton David T | SVP, General Counsel | Mar 19, 2017 | Option Exercise | $30.30 | 152 | 4,606 | 22,301 | Mar 21, 2017, 06:07 PM |
Mahatme Sandesh | EVP, CFO & CBO | Mar 19, 2017 | Option Exercise | $30.30 | 171 | 5,181 | 32,361 | Mar 21, 2017, 06:05 PM |
Ruff Shamim | SVP, Regulatory Affairs & Qual | Mar 19, 2017 | Option Exercise | $30.30 | 177 | 5,363 | 21,062 | Mar 21, 2017, 06:01 PM |
Kaye Edward M. MD | President, CEO & CMO | Jan 20, 2017 | Option Exercise | $32.66 | 4,466 | 145,860 | 71,169 | Jan 24, 2017, 05:52 PM |
Howton David T | SVP, General Counsel | Nov 09, 2016 | Option Exercise | $23.85 | 1,000 | 23,850 | 22,453 | Nov 10, 2016, 08:27 AM |
Mahatme Sandesh | Senior Vice President, CFO | Nov 09, 2016 | Option Exercise | $23.85 | 1,000 | 23,850 | 32,532 | Nov 10, 2016, 08:26 AM |
Ruff Shamim | SVP, Regulatory Affairs & Qual | Nov 08, 2016 | Option Exercise | $26.24 | 1,000 | 26,240 | 21,239 | Nov 10, 2016, 08:20 AM |
Kaye Edward M. MD | President, CEO & CMO | Nov 09, 2016 | Option Exercise | $8.28 | 3,000 | 24,840 | 75,635 | Nov 10, 2016, 08:19 AM |
Kaye Edward M. MD | President, CEO & CMO | Oct 20, 2016 | Option Exercise | $49.05 | 4,348 | 213,269 | 72,635 | Oct 24, 2016, 04:33 PM |
Mahatme Sandesh | Senior Vice President, CFO | Oct 17, 2016 | Option Exercise | $13.90 | 30,000 | 417,000 | 61,532 | Oct 19, 2016, 04:22 PM |
Mahatme Sandesh | Senior Vice President, CFO | Oct 17, 2016 | Sale | $50.08 | 30,000 | 1,502,502 | 31,532 | Oct 19, 2016, 04:22 PM |
Ruff Shamim | SVP, Regulatory Affairs & Qual | Sep 22, 2016 | Option Exercise | $13.90 | 7,311 | 101,623 | 27,550 | Sep 30, 2016, 09:58 PM |
Ruff Shamim | SVP, Regulatory Affairs & Qual | Sep 22, 2016 | Sale | $60.00 | 7,311 | 438,660 | 20,239 | Sep 30, 2016, 09:58 PM |
Kaye Edward M. MD | President, CEO & CMO | Sep 22, 2016 | Option Exercise | $8.28 | 40,179 | 332,682 | 117,162 | Sep 26, 2016, 04:23 PM |
Kaye Edward M. MD | President, CEO & CMO | Sep 22, 2016 | Sale | $60.00 | 40,179 | 2,410,740 | 76,983 | Sep 26, 2016, 04:23 PM |
Howton David T | SVP, General Counsel | Sep 22, 2016 | Option Exercise | $13.90 | 7,000 | 97,300 | 28,453 | Sep 26, 2016, 04:19 PM |
Howton David T | SVP, General Counsel | Sep 22, 2016 | Sale | $60.00 | 7,000 | 420,000 | 21,453 | Sep 26, 2016, 04:19 PM |
Aphale Jayant | VP, Technical Operations | Sep 19, 2016 | Option Exercise | $4.62 | 35,000 | 161,700 | 36,490 | Sep 21, 2016, 09:31 PM |
Aphale Jayant | VP, Technical Operations | Sep 19, 2016 | Sale | $50.00 | 35,000 | 1,750,000 | 11,490 | Sep 21, 2016, 09:31 PM |
Kaye Edward M. MD | President, CEO & CMO | Sep 19, 2016 | Option Exercise | $6.94 | 24,352 | 168,941 | 89,983 | Sep 21, 2016, 09:29 PM |
Kaye Edward M. MD | President, CEO & CMO | Sep 19, 2016 | Sale | $50.00 | 24,352 | 1,217,600 | 76,983 | Sep 21, 2016, 09:29 PM |
Howton David T | SVP, General Counsel | Sep 19, 2016 | Option Exercise | $13.90 | 8,000 | 111,200 | 11,168 | Sep 21, 2016, 09:28 PM |
Howton David T | SVP, General Counsel | Sep 19, 2016 | Sale | $50.00 | 9,304 | 465,200 | 21,453 | Sep 21, 2016, 09:28 PM |
Kaye Edward M. MD | SVP Interim CEO & CMO | Sep 14, 2016 | Sale | $30.00 | 24,557 | 736,710 | 76,983 | Sep 16, 2016, 04:04 PM |
Kaye Edward M. MD | SVP Interim CEO & CMO | Aug 31, 2016 | Option Exercise | $26.07 | 1,487 | 38,766 | 101,540 | Sep 02, 2016, 04:43 PM |
Mahatme Sandesh | Senior Vice President, CFO | Aug 31, 2016 | Option Exercise | $26.07 | 1,013 | 26,409 | 7,102 | Sep 02, 2016, 04:37 PM |
Aphale Jayant | SVP, Technical Operations | Aug 31, 2016 | Option Exercise | $26.07 | 765 | 19,944 | 11,490 | Sep 02, 2016, 04:34 PM |
Howton David T | SVP, General Counsel | Aug 31, 2016 | Option Exercise | $26.07 | 898 | 23,411 | 3,168 | Sep 02, 2016, 04:32 PM |
Kaye Edward M. MD | SVP Interim CEO & CMO | Jul 20, 2016 | Option Exercise | $22.46 | 3,001 | 67,402 | 103,027 | Jul 22, 2016, 05:20 PM |
Kaye Edward M. MD | SVP Interim CEO & CMO | Apr 20, 2016 | Option Exercise | $19.71 | 3,001 | 59,150 | 106,028 | Apr 22, 2016, 04:36 PM |
BEHRENS M KATHLEEN | Director | Mar 16, 2016 | Buy | $14.54 | 10,000 | 145,433 | 21,855 | Mar 16, 2016, 08:15 PM |
BEHRENS M KATHLEEN | Director | Mar 14, 2016 | Buy | $16.54 | 65,000 | 1,075,275 | 112,166 | Mar 16, 2016, 08:15 PM |
Barry Richard | Director | Mar 14, 2016 | Buy | $15.66 | 75,000 | 1,174,185 | 3,241,014 | Mar 16, 2016, 08:09 PM |
Price Ben Gil | Director | Mar 14, 2016 | Buy | $16.70 | 4,500 | 75,144 | 42,830 | Mar 16, 2016, 08:07 PM |
Kaye Edward M. MD | SVP Interim CEO & CMO | Jan 20, 2016 | Option Exercise | $13.26 | 3,368 | 44,660 | 103,525 | Jan 25, 2016, 01:28 PM |
Kaye Edward M. MD | SVP Interim CEO & CMO | Oct 20, 2015 | Option Exercise | $26.74 | 3,001 | 80,247 | 106,893 | Oct 22, 2015, 06:24 PM |
Kaye Edward M. MD | SVP Interim CEO & CMO | Jul 20, 2015 | Option Exercise | $33.48 | 3,000 | 100,440 | 109,094 | Jul 31, 2015, 04:36 PM |
Kaye Edward M. MD | SVP & Chief Medical Officer | Feb 27, 2015 | Buy | $11.81 | 800 | 9,452 | 1,311 | Mar 03, 2015, 06:48 PM |
Christopher Nishan Garabedian | President and CEO | Feb 27, 2015 | Buy | $11.81 | 800 | 9,452 | 29,552 | Mar 03, 2015, 06:47 PM |
CHASE ANTHONY R | Director | Aug 12, 2014 | Option Exercise | $10.68 | 23,450 | 250,446 | 66,194 | Aug 14, 2014, 04:24 PM |
Aphale Jayant | SVP Technical Operations | Nov 12, 2013 | Sale | $12.56 | 15,933 | 200,134 | 8,500 | Nov 14, 2013, 09:31 PM |
CHASE ANTHONY R | Director | Nov 14, 2013 | Buy | $13.95 | 10,000 | 139,483 | 41,744 | Nov 14, 2013, 09:30 PM |
BEHRENS M KATHLEEN | Director | Sep 16, 2013 | Buy | $37.04 | 6,500 | 240,778 | 44,166 | Sep 18, 2013, 09:00 AM |
HODGMAN JOHN | Director | Sep 03, 2013 | Option Exercise | $17.52 | 5,556 | 97,341 | 9,889 | Sep 05, 2013, 06:26 PM |
HODGMAN JOHN | Director | Sep 03, 2013 | Sale | $34.97 | 5,556 | 194,316 | 4,333 | Sep 05, 2013, 06:26 PM |
CHASE ANTHONY R | Director | Aug 22, 2013 | Buy | $32.68 | 3,500 | 114,373 | 31,744 | Aug 23, 2013, 09:01 AM |
Price Ben Gil | Director | Aug 19, 2013 | Buy | $31.17 | 500 | 15,587 | 35,330 | Aug 20, 2013, 04:08 PM |
Mahatme Sandesh | Senior Vice President, CFO | Aug 20, 2013 | Buy | $31.10 | 5,000 | 155,500 | 5,000 | Aug 20, 2013, 01:42 PM |
CHASE ANTHONY R | Director | Jun 14, 2013 | Buy | $38.50 | 10,000 | 385,043 | 28,244 | Jun 18, 2013, 04:51 PM |
CHASE ANTHONY R | Director | Nov 28, 2012 | Sale | $29.52 | 8,900 | 262,689 | 24,544 | Nov 29, 2012, 01:46 PM |
CHASE ANTHONY R | Director | Nov 27, 2012 | Sale | $29.04 | 1,100 | 31,940 | 26,144 | Nov 29, 2012, 01:46 PM |
CHASE ANTHONY R | Director | Nov 14, 2012 | Sale | $25.70 | 10,000 | 257,002 | 28,044 | Nov 15, 2012, 07:12 PM |
CHASE ANTHONY R | Director | Sep 07, 2012 | Sale | $14.45 | 33,000 | 476,959 | 56,944 | Sep 11, 2012, 05:40 PM |
BEHRENS M KATHLEEN | Director | Sep 07, 2012 | Buy | $14.73 | 17,500 | 257,724 | 36,666 | Sep 11, 2012, 05:40 PM |
Price Ben Gil | Director | Mar 14, 2012 | Buy | $1.29 | 30,000 | 38,850 | 197,982 | Mar 15, 2012, 01:37 PM |
Christopher Nishan Garabedian | President and CEO | Dec 15, 2011 | Buy | $0.58 | 300,000 | 173,640 | 430,000 | Dec 16, 2011, 11:48 AM |
CHASE ANTHONY R | Director | Sep 13, 2011 | Buy | $1.20 | 20,000 | 24,000 | 416,467 | Sep 14, 2011, 05:45 PM |
Price Ben Gil | Director | Apr 06, 2011 | Buy | $1.50 | 20,000 | 30,000 | 162,982 | Apr 06, 2011, 05:38 PM |
Christopher Nishan Garabedian | President and CEO | Apr 06, 2011 | Buy | $1.50 | 130,000 | 195,000 | 130,000 | Apr 06, 2011, 05:37 PM |
BEHRENS M KATHLEEN | Director | Apr 06, 2011 | Buy | $1.50 | 100,000 | 150,000 | 105,000 | Apr 06, 2011, 05:36 PM |
BOYLE J DAVID II | CEO | Aug 27, 2010 | Buy | $2.13 | 5,000 | 10,645 | 70,282 | Aug 27, 2010, 06:02 PM |
Price Ben Gil | Director | Aug 13, 2010 | Buy | $1.93 | 4,000 | 7,720 | 102,982 | Aug 16, 2010, 03:17 PM |
Hudson Leslie | Former CEO | Jul 30, 2010 | Option Exercise | $1.09 | 183,486 | 200,000 | 568,045 | Aug 02, 2010, 07:28 PM |
Hudson Leslie | Former CEO | Jul 30, 2010 | Sale | $1.93 | 183,486 | 354,113 | 518,045 | Aug 02, 2010, 07:28 PM |
Hudson Leslie | Former CEO | Jul 28, 2010 | Option Exercise | $1.09 | 183,486 | 200,000 | 568,045 | Jul 29, 2010, 08:00 PM |
Hudson Leslie | Former CEO | Jul 28, 2010 | Sale | $1.82 | 183,486 | 334,373 | 498,045 | Jul 29, 2010, 08:00 PM |
Hudson Leslie | Former CEO | Jul 26, 2010 | Option Exercise | $1.45 | 129,083 | 187,170 | 513,642 | Jul 28, 2010, 12:48 PM |
Hudson Leslie | Former CEO | Jul 26, 2010 | Sale | $1.90 | 129,083 | 245,897 | 509,559 | Jul 28, 2010, 12:48 PM |
Hudson Leslie | Former CEO | Jul 23, 2010 | Option Exercise | $1.45 | 205,400 | 297,830 | 589,959 | Jul 26, 2010, 05:37 PM |
Hudson Leslie | Former CEO | Jul 23, 2010 | Sale | $1.80 | 205,400 | 369,720 | 384,559 | Jul 26, 2010, 05:37 PM |
Hudson Leslie | Former CEO | Jul 22, 2010 | Option Exercise | $1.45 | 265,517 | 385,000 | 650,076 | Jul 23, 2010, 05:06 PM |
Hudson Leslie | Former CEO | Jul 22, 2010 | Sale | $1.80 | 265,517 | 477,513 | 596,280 | Jul 23, 2010, 05:06 PM |
Owner | Relationship | Date | Value($) |
Chambers Michael Andrew | Director | 08/14/2023 | 1,092,429 |
Chambers Michael Andrew | Director | 08/11/2023 | 2,559,272 |
Chambers Michael Andrew | Director | 08/10/2023 | 3,701,067 |
Wigzell Hans Lennart Rudolf | Director | 08/04/2023 | 435,450 |
Wigzell Hans Lennart Rudolf | Director | 08/04/2023 | 1,600,800 |
Brown Ryan Edward | EVP, General Counsel | 06/01/2023 | 11,000 |
Arif Bilal | Chief Tech Ops Officer | 03/30/2023 | 41,955 |
Rodino-Klapac Louise | Head of R&D, CSO | 03/08/2023 | 139,709 |
Estepan Ian Michael | Chief Financial Officer | 03/08/2023 | 113,973 |
Brown Ryan Edward | SVP, General Counsel | 03/08/2023 | 97,276 |
Arif Bilal | Chief Tech Ops Officer | 03/08/2023 | 48,102 |
Arif Bilal | Chief Tech Ops Officer | 03/06/2023 | 53,451 |
Estepan Ian Michael | Chief Financial Officer | 03/06/2023 | 215,378 |
Rodino-Klapac Louise | Head of R&D, CSO | 03/06/2023 | 178,276 |
Brown Ryan Edward | SVP, General Counsel | 03/06/2023 | 208,303 |
Arif Bilal | Chief Tech Ops Officer | 03/01/2023 | 37,188 |
Brown Ryan Edward | SVP, General Counsel | 03/01/2023 | 28,924 |
Estepan Ian Michael | Chief Financial Officer | 03/01/2023 | 55,781 |
Rodino-Klapac Louise | Head of R&D, CSO | 03/01/2023 | 77,032 |
BEHRENS M KATHLEEN | Director | 12/19/2022 | 698,400 |
Rodino-Klapac Louise | Head of R&D, CSO | 11/17/2022 | 456,978 |
Mayo Stephen | Director | 11/17/2022 | 94,311 |
Chambers Michael Andrew | Director | 09/14/2022 | 5,963,124 |
Chambers Michael Andrew | Director | 08/19/2022 | 4,999,230 |
Brown Ryan Edward | SVP, General Counsel | 06/01/2022 | 3,924 |
Estepan Ian Michael | Chief Financial Officer | 03/07/2022 | 31,585 |
Estepan Ian Michael | Chief Financial Officer | 03/04/2022 | 103,594 |
Brown Ryan Edward | SVP, General Counsel | 03/07/2022 | 12,142 |
Brown Ryan Edward | SVP, General Counsel | 03/04/2022 | 89,971 |
Ciambrone William | EVP | 03/04/2022 | 91,872 |
Rodino-Klapac Louise | Head of R&D, CSO | 03/04/2022 | 96,307 |
Rodino-Klapac Louise | Head of R&D, CSO | 03/01/2022 | 42,929 |
Estepan Ian Michael | Chief Financial Officer | 03/01/2022 | 28,219 |
Brown Ryan Edward | SVP, General Counsel | 03/01/2022 | 13,809 |
BEHRENS M KATHLEEN | Director | 12/15/2021 | 50,400 |
Rodino-Klapac Louise | Head of R&D, CSO | 11/24/2021 | 299,867 |
INGRAM DOUGLAS S | President & CEO | 11/17/2021 | 2,000,579 |
Estepan Ian Michael | Chief Financial Officer | 09/08/2021 | 127,065 |
INGRAM DOUGLAS S | President & CEO | 06/26/2021 | 1,432,085 |
BEHRENS M KATHLEEN | Director | 03/10/2021 | 211,500 |
BEHRENS M KATHLEEN | Director | 03/10/2021 | 428,800 |
Wigzell Hans Lennart Rudolf | Director | 03/08/2021 | 349,200 |
Wigzell Hans Lennart Rudolf | Director | 03/08/2021 | 835,100 |
O'Neill Gilmore Neil | EVP, R&D & CMO | 02/28/2021 | 45,572 |
Brown Ryan Edward | SVP, General Counsel | 03/04/2021 | 15,344 |
Brown Ryan Edward | SVP, General Counsel | 02/28/2021 | 18,786 |
Rodino-Klapac Louise | Chief Scientific Officer | 02/28/2021 | 49,138 |
Estepan Ian Michael | Chief Financial Officer | 03/05/2021 | 29,374 |
Estepan Ian Michael | Chief Financial Officer | 02/28/2021 | 27,743 |
INGRAM DOUGLAS S | President & CEO | 12/31/2020 | 6,332,681 |
Bratica Joseph | Principal Financial Officer | 12/11/2020 | 79,667 |
Bratica Joseph | Principal Financial Officer | 12/11/2020 | 183,975 |
Bratica Joseph | Principal Financial Officer | 12/08/2020 | 33,300 |
Bratica Joseph | Principal Financial Officer | 12/08/2020 | 180,000 |
Wigzell Hans Lennart Rudolf | Director | 08/10/2020 | 349,200 |
Wigzell Hans Lennart Rudolf | Director | 08/10/2020 | 1,590,044 |
Barry Richard | Director | 08/07/2020 | 4,754,972 |
Bratica Joseph | Principal Financial Officer | 08/03/2020 | 33,300 |
Bratica Joseph | Principal Financial Officer | 08/03/2020 | 174,375 |
Mahatme Sandesh | EVP, CFO & CBO | 07/08/2020 | 74,941 |
Howton David T | EVP, General Counsel | 06/22/2020 | 2,708,440 |
Howton David T | EVP, General Counsel | 06/22/2020 | 17,962,831 |
Wigzell Hans Lennart Rudolf | Director | 05/20/2020 | 50,400 |
Wigzell Hans Lennart Rudolf | Director | 05/20/2020 | 753,210 |
Barry Richard | Director | 05/15/2020 | 4,237,946 |
Wigzell Hans Lennart Rudolf | Director | 03/04/2020 | 42,300 |
Wigzell Hans Lennart Rudolf | Director | 03/04/2020 | 584,450 |
INGRAM DOUGLAS S | President & CEO | 12/31/2019 | 4,798,352 |
Cumbo Alexander | EVP, Chief Commercial Officer | 12/13/2019 | 775,232 |
Cumbo Alexander | EVP, Chief Commercial Officer | 12/13/2019 | 5,271,000 |
Howton David T | EVP, General Counsel | 12/13/2019 | 1,675,439 |
Howton David T | EVP, General Counsel | 12/13/2019 | 9,789,000 |
Mahatme Sandesh | EVP, CFO & CBO | 12/13/2019 | 3,610,443 |
Mahatme Sandesh | EVP, CFO & CBO | 12/13/2019 | 15,687,500 |
Howton David T | EVP, General Counsel | 11/22/2019 | 300,084 |
Howton David T | EVP, General Counsel | 11/22/2019 | 552,667 |
Howton David T | EVP, General Counsel | 11/22/2019 | 2,625,000 |
Barry Richard | Director | 09/13/2019 | 289,504 |
Barry Richard | Director | 09/12/2019 | 147,950 |
BONNEY MICHAEL W | Director | 09/09/2019 | 173,480 |
BEHRENS M KATHLEEN | Director | 09/05/2019 | 39,000 |
BEHRENS M KATHLEEN | Director | 09/06/2019 | 219,950 |
Mahatme Sandesh | EVP, CFO & CBO | 08/21/2019 | 5,832,698 |
Mahatme Sandesh | EVP, CFO & CBO | 08/21/2019 | 2,385,000 |
Barry Richard | Director | 08/20/2019 | 496,592 |
Mahatme Sandesh | EVP, CFO & CBO | 08/15/2019 | 241,232 |
Barry Richard | Director | 08/14/2019 | 453,250 |
Barry Richard | Director | 08/12/2019 | 159,250 |
INGRAM DOUGLAS S | President & CEO | 08/12/2019 | 2,000,160 |
O'Neill Gilmore Neil | EVP, R&D & CMO | 05/24/2019 | 552,405 |
Wigzell Hans Lennart Rudolf | Director | 05/23/2019 | 78,000 |
Wigzell Hans Lennart Rudolf | Director | 05/23/2019 | 1,200,000 |
Mahatme Sandesh | EVP, CFO & CBO | 03/28/2019 | 350,462 |
Howton David T | EVP, General Counsel | 03/28/2019 | 280,322 |
Cumbo Alexander | EVP, Chief Commercial Officer | 03/28/2019 | 256,942 |
Mahatme Sandesh | EVP, CFO & CBO | 03/19/2019 | 331,984 |
Mahatme Sandesh | EVP, CFO & CBO | 03/19/2019 | 332,308 |
Mahatme Sandesh | EVP, CFO & CBO | 02/07/2019 | 1,550,250 |
Mahatme Sandesh | EVP, CFO & CBO | 02/07/2019 | 9,425,000 |
Cumbo Alexander | SVP, Chief Commercial Officer | 02/01/2019 | 169,035 |
Cumbo Alexander | SVP, Chief Commercial Officer | 02/01/2019 | 2,100,000 |
Howton David T | SVP, General Counsel | 02/01/2019 | 465,391 |
Howton David T | SVP, General Counsel | 02/01/2019 | 4,200,000 |
Mahatme Sandesh | EVP, CFO & CBO | 01/31/2019 | 505,572 |
Mahatme Sandesh | EVP, CFO & CBO | 01/30/2019 | 800,077 |
Mahatme Sandesh | EVP, CFO & CBO | 01/31/2019 | 2,771,003 |
Mahatme Sandesh | EVP, CFO & CBO | 01/30/2019 | 5,694,260 |
Wigzell Hans Lennart Rudolf | Director | 11/01/2018 | 59,603 |
Wigzell Hans Lennart Rudolf | Director | 11/01/2018 | 936,714 |
BEHRENS M KATHLEEN | Director | 10/31/2018 | 39,600 |
BEHRENS M KATHLEEN | Director | 10/31/2018 | 1,317,100 |
INGRAM DOUGLAS S | President & CEO | 10/30/2018 | 2,009,872 |
Mahatme Sandesh | EVP, CFO & CBO | 10/24/2018 | 1,330,389 |
Mahatme Sandesh | EVP, CFO & CBO | 10/24/2018 | 13,735,116 |
INGRAM DOUGLAS S | President & CEO | 08/15/2018 | 2,004,208 |
Cumbo Alexander | SVP, Chief Commercial Officer | 08/08/2018 | 726,120 |
Howton David T | SVP, General Counsel | 08/08/2018 | 822,936 |
Mahatme Sandesh | EVP, CFO & CBO | 08/08/2018 | 1,028,791 |
Howton David T | SVP, General Counsel | 07/16/2018 | 692,691 |
Howton David T | SVP, General Counsel | 07/16/2018 | 6,823,000 |
Cumbo Alexander | SVP, Chief Commercial Officer | 07/09/2018 | 465,415 |
Cumbo Alexander | SVP, Chief Commercial Officer | 07/09/2018 | 4,638,944 |
Barry Richard | Director | 06/27/2018 | 9,775,500 |
INGRAM DOUGLAS S | President & CEO | 06/26/2018 | 5,007,291 |
Ruff Shamim | SVP, Chief Regulatory Affairs | 05/22/2018 | 116,432 |
Mahatme Sandesh | EVP, CFO & CBO | 05/22/2018 | 180,581 |
Howton David T | SVP, General Counsel | 05/22/2018 | 139,719 |
Cumbo Alexander | SVP, Chief Commercial Officer | 05/22/2018 | 128,031 |
Ruff Shamim | SVP, Chief Regulatory Affairs | 03/15/2018 | 59,778 |
Ruff Shamim | SVP, Chief Regulatory Affairs | 03/15/2018 | 59,813 |
Howton David T | SVP, General Counsel | 03/15/2018 | 55,230 |
Howton David T | SVP, General Counsel | 03/15/2018 | 55,382 |
Cumbo Alexander | SVP, Chief Commercial Officer | 03/15/2018 | 51,412 |
Cumbo Alexander | SVP, Chief Commercial Officer | 03/15/2018 | 51,600 |
Mahatme Sandesh | EVP, CFO & CBO | 03/15/2018 | 59,615 |
Mahatme Sandesh | EVP, CFO & CBO | 03/15/2018 | 59,625 |
Wigzell Hans Lennart Rudolf | Director | 11/30/2017 | 49,202 |
Wigzell Hans Lennart Rudolf | Director | 11/30/2017 | 372,619 |
INGRAM DOUGLAS S | President & CEO | 11/08/2017 | 1,999,957 |
Ruff Shamim | SVP, Regulatory Affairs & Qual | 11/06/2017 | 147,600 |
Ruff Shamim | SVP, Regulatory Affairs & Qual | 11/06/2017 | 550,000 |
Ruff Shamim | SVP, Regulatory Affairs & Qual | 10/03/2017 | 169,740 |
Ruff Shamim | SVP, Regulatory Affairs & Qual | 10/03/2017 | 575,000 |
Ruff Shamim | SVP, Regulatory Affairs & Qual | 08/03/2017 | 109,170 |
Mahatme Sandesh | EVP, CFO & CBO | 08/03/2017 | 237,280 |
Howton David T | SVP, General Counsel | 08/03/2017 | 175,839 |
Kaye Edward M. MD | Director | 08/03/2017 | 632,710 |
Cumbo Alexander | SVP, Chief Commercial Officer | 08/03/2017 | 120,042 |
INGRAM DOUGLAS S | President & CEO | 07/27/2017 | 1,999,965 |
Mahatme Sandesh | EVP, CFO & CBO | 07/21/2017 | 35,775 |
Mahatme Sandesh | EVP, CFO & CBO | 07/20/2017 | 769,107 |
Mahatme Sandesh | EVP, CFO & CBO | 07/20/2017 | 2,050,000 |
Kaye Edward M. MD | Director | 07/20/2017 | 178,005 |
Kaye Edward M. MD | Director | 07/20/2017 | 410,000 |
Ruff Shamim | SVP, Regulatory Affairs & Qual | 07/21/2017 | 83,133 |
Ruff Shamim | SVP, Regulatory Affairs & Qual | 07/20/2017 | 85,688 |
Ruff Shamim | SVP, Regulatory Affairs & Qual | 07/21/2017 | 259,072 |
Ruff Shamim | SVP, Regulatory Affairs & Qual | 07/20/2017 | 262,500 |
Howton David T | SVP, General Counsel | 07/20/2017 | 342,750 |
Howton David T | SVP, General Counsel | 07/21/2017 | 20,565 |
Howton David T | SVP, General Counsel | 07/20/2017 | 1,025,000 |
Cumbo Alexander | SVP, Chief Commercial Officer | 07/20/2017 | 34,275 |
Cumbo Alexander | SVP, Chief Commercial Officer | 07/20/2017 | 242,638 |
Kaye Edward M. MD | President & CEO | 04/20/2017 | 141,516 |
Howton David T | SVP, General Counsel | 03/19/2017 | 4,606 |
Mahatme Sandesh | EVP, CFO & CBO | 03/19/2017 | 5,181 |
Ruff Shamim | SVP, Regulatory Affairs & Qual | 03/19/2017 | 5,363 |
Kaye Edward M. MD | President, CEO & CMO | 01/20/2017 | 145,860 |
Howton David T | SVP, General Counsel | 11/09/2016 | 23,850 |
Mahatme Sandesh | Senior Vice President, CFO | 11/09/2016 | 23,850 |
Ruff Shamim | SVP, Regulatory Affairs & Qual | 11/08/2016 | 26,240 |
Kaye Edward M. MD | President, CEO & CMO | 11/09/2016 | 24,840 |
Kaye Edward M. MD | President, CEO & CMO | 10/20/2016 | 213,269 |
Mahatme Sandesh | Senior Vice President, CFO | 10/17/2016 | 417,000 |
Mahatme Sandesh | Senior Vice President, CFO | 10/17/2016 | 1,502,502 |
Ruff Shamim | SVP, Regulatory Affairs & Qual | 09/22/2016 | 101,623 |
Ruff Shamim | SVP, Regulatory Affairs & Qual | 09/22/2016 | 438,660 |
Kaye Edward M. MD | President, CEO & CMO | 09/22/2016 | 332,682 |
Kaye Edward M. MD | President, CEO & CMO | 09/22/2016 | 2,410,740 |
Howton David T | SVP, General Counsel | 09/22/2016 | 97,300 |
Howton David T | SVP, General Counsel | 09/22/2016 | 420,000 |
Aphale Jayant | VP, Technical Operations | 09/19/2016 | 161,700 |
Aphale Jayant | VP, Technical Operations | 09/19/2016 | 1,750,000 |
Kaye Edward M. MD | President, CEO & CMO | 09/19/2016 | 168,941 |
Kaye Edward M. MD | President, CEO & CMO | 09/19/2016 | 1,217,600 |
Howton David T | SVP, General Counsel | 09/19/2016 | 111,200 |
Howton David T | SVP, General Counsel | 09/19/2016 | 465,200 |
Kaye Edward M. MD | SVP Interim CEO & CMO | 09/14/2016 | 736,710 |
Kaye Edward M. MD | SVP Interim CEO & CMO | 08/31/2016 | 38,766 |
Mahatme Sandesh | Senior Vice President, CFO | 08/31/2016 | 26,409 |
Aphale Jayant | SVP, Technical Operations | 08/31/2016 | 19,944 |
Howton David T | SVP, General Counsel | 08/31/2016 | 23,411 |
Kaye Edward M. MD | SVP Interim CEO & CMO | 07/20/2016 | 67,402 |
Kaye Edward M. MD | SVP Interim CEO & CMO | 04/20/2016 | 59,150 |
BEHRENS M KATHLEEN | Director | 03/16/2016 | 145,433 |
BEHRENS M KATHLEEN | Director | 03/14/2016 | 1,075,275 |
Barry Richard | Director | 03/14/2016 | 1,174,185 |
Price Ben Gil | Director | 03/14/2016 | 75,144 |
Kaye Edward M. MD | SVP Interim CEO & CMO | 01/20/2016 | 44,660 |
Kaye Edward M. MD | SVP Interim CEO & CMO | 10/20/2015 | 80,247 |
Kaye Edward M. MD | SVP Interim CEO & CMO | 07/20/2015 | 100,440 |
Kaye Edward M. MD | SVP & Chief Medical Officer | 02/27/2015 | 9,452 |
Christopher Nishan Garabedian | President and CEO | 02/27/2015 | 9,452 |
CHASE ANTHONY R | Director | 08/12/2014 | 250,446 |
Aphale Jayant | SVP Technical Operations | 11/12/2013 | 200,134 |
CHASE ANTHONY R | Director | 11/14/2013 | 139,483 |
BEHRENS M KATHLEEN | Director | 09/16/2013 | 240,778 |
HODGMAN JOHN | Director | 09/03/2013 | 97,341 |
HODGMAN JOHN | Director | 09/03/2013 | 194,316 |
CHASE ANTHONY R | Director | 08/22/2013 | 114,373 |
Price Ben Gil | Director | 08/19/2013 | 15,587 |
Mahatme Sandesh | Senior Vice President, CFO | 08/20/2013 | 155,500 |
CHASE ANTHONY R | Director | 06/14/2013 | 385,043 |
CHASE ANTHONY R | Director | 11/28/2012 | 262,689 |
CHASE ANTHONY R | Director | 11/27/2012 | 31,940 |
CHASE ANTHONY R | Director | 11/14/2012 | 257,002 |
CHASE ANTHONY R | Director | 09/07/2012 | 476,959 |
BEHRENS M KATHLEEN | Director | 09/07/2012 | 257,724 |
Price Ben Gil | Director | 03/14/2012 | 38,850 |
Christopher Nishan Garabedian | President and CEO | 12/15/2011 | 173,640 |
CHASE ANTHONY R | Director | 09/13/2011 | 24,000 |
Price Ben Gil | Director | 04/06/2011 | 30,000 |
Christopher Nishan Garabedian | President and CEO | 04/06/2011 | 195,000 |
BEHRENS M KATHLEEN | Director | 04/06/2011 | 150,000 |
BOYLE J DAVID II | CEO | 08/27/2010 | 10,645 |
Price Ben Gil | Director | 08/13/2010 | 7,720 |
Hudson Leslie | Former CEO | 07/30/2010 | 200,000 |
Hudson Leslie | Former CEO | 07/30/2010 | 354,113 |
Hudson Leslie | Former CEO | 07/28/2010 | 200,000 |
Hudson Leslie | Former CEO | 07/28/2010 | 334,373 |
Hudson Leslie | Former CEO | 07/26/2010 | 187,170 |
Hudson Leslie | Former CEO | 07/26/2010 | 245,897 |
Hudson Leslie | Former CEO | 07/23/2010 | 297,830 |
Hudson Leslie | Former CEO | 07/23/2010 | 369,720 |
Hudson Leslie | Former CEO | 07/22/2010 | 385,000 |
Hudson Leslie | Former CEO | 07/22/2010 | 477,513 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 5,503,466 | 0.02% | 4.18% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 1,388,083 | 0.02% | 9.99% | Other |
FARALLON CAPITAL MANAGEMENT LLC | 1,205,200 | 0.77% | 31.96% | Event Driven, Value |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 655,000 | 0.16% | 63.61% | Other |
ORBIMED ADVISORS LLC | 654,000 | 1.36% | -24.4% | Other |
RENAISSANCE TECHNOLOGIES LLC | 642,078 | 0.11% | -20.38% | Other |
CAPITAL RESEARCH GLOBAL INVESTORS | 557,383 | 0.02% | 109.59% | Growth At A Reasonable Price |
D. E. SHAW & CO., INC. | 274,919 | 0.03% | -67.72% | Other |
BALYASNY ASSET MANAGEMENT L.P. | 135,400 (Put) | 0.03% | -44.82% | Event Driven |
BALYASNY ASSET MANAGEMENT L.P. | 126,900 (Call) | 0.03% | 50.18% | Event Driven |
CANDRIAM S.C.A. | 100,000 | 0.08% | -18.16% | Other |
PALO ALTO INVESTORS LP | 94,030 | 0.87% | New | Other |
BRIDGEWATER ASSOCIATES, LP | 30,856 | 0.02% | 1.27% | Other |
FISHER ASSET MANAGEMENT, LLC | 17,220 | 0.00109% | 37.73% | Other |
PLATINUM INVESTMENT MANAGEMENT LTD | 10,034 | 0.04% | No change | Growth At A Reasonable Price, Value |
AQR CAPITAL MANAGEMENT LLC | 9,721 | 0.00237% | 23.18% | Other |
SUVRETTA CAPITAL MANAGEMENT, LLC | 6,058 | 0.04% | New | Growth At A Reasonable Price |
DUPONT CAPITAL MANAGEMENT CORP | 1,319 | 0.00744% | 164.86% | Other |
Period of Report: 06/30/2023
10-K/10-Q Filings: View